Valneva
1 articles

Lyme Disease Vaccine Candidate VLA15 Advances Through Phase 1 Trials
Jul 16, 2018 | Emily WolfsonValneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease...